Legal & General Group
SLXP

Legal & General Group’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Legal & General Group’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-14,949
Closed -$2.58M – 2830
2015
Q1 		$2.58M Buy
14,949
+7,971
+114% +$1.17M ﹤0.01% 853
2014
Q4 		$802K Buy
+6,978
New +$845K ﹤0.01% 1145

Other funds holding SLXP

MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Legal & General Group's SLXP Position: Q2 2015 in Review

Legal & General Group sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 14,949 shares — an estimated $2.58M sold.

Legal & General Group first reported a position in SLXP in Q4 2014 and held it in 2 quarters. The position peaked at $2.58M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • Legal & General Group reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • Legal & General Group sold 14,949 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $2.58M.
  • Legal & General Group first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q4 2014 and held it in 2 quarters.
  • Legal & General Group's SALIX PHARMACEUTICALS LTD DEL position peaked at $2.58M in Q1 2015.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Legal & General Group's 13F filing for Q2 2015, filed 31 Jul 2015.